v3.26.1
Unaudited Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Common shares
Additional paid in capital
Contributed surplus
Retained earnings
Non-controlling Interests
Outstanding shares at beginning of period (in shares) at Dec. 31, 2024   43,900,000        
Equity at beginning of period at Dec. 31, 2024 $ 154.7 $ 43.9 $ 14.4 $ 76.8 $ 19.6 $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares (in shares)   2,650,000        
Issuance of common shares 15.1 $ 2.7 12.4      
Equity issuance costs (0.3)   (0.3)      
Share based compensation 0.1   0.1      
Cash distributions to shareholders (0.7)     (0.7)    
Net income (loss) (6.4)       (6.4)  
Outstanding shares at end of period (in shares) at Mar. 31, 2025   46,550,000        
Equity at end of period at Mar. 31, 2025 162.5 $ 46.6 26.6 76.1 13.2 0.0
Outstanding shares at beginning of period (in shares) at Dec. 31, 2024   43,900,000        
Equity at beginning of period at Dec. 31, 2024 154.7 $ 43.9 14.4 76.8 19.6 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (5.3)          
Outstanding shares at end of period (in shares) at Jun. 30, 2025   46,550,000        
Equity at end of period at Jun. 30, 2025 159.3 $ 46.6 26.7 71.7 14.3 0.0
Outstanding shares at beginning of period (in shares) at Mar. 31, 2025   46,550,000        
Equity at beginning of period at Mar. 31, 2025 162.5 $ 46.6 26.6 76.1 13.2 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share based compensation 0.1   0.1      
Cash distributions to shareholders (4.4)     (4.4)    
Net income (loss) 1.1       1.1  
Outstanding shares at end of period (in shares) at Jun. 30, 2025   46,550,000        
Equity at end of period at Jun. 30, 2025 $ 159.3 $ 46.6 26.7 71.7 14.3 0.0
Outstanding shares at beginning of period (in shares) at Dec. 31, 2025 46,650,000 46,650,000        
Equity at beginning of period at Dec. 31, 2025 $ 161.7 $ 46.7 27.4 50.3 37.3 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares (in shares)   100,000        
Issuance of common shares 0.7 $ 0.1 0.6      
Share based compensation 0.1   0.1      
Cash distributions to shareholders (11.7)     (11.7)    
Net income (loss) 5.0       5.0  
Outstanding shares at end of period (in shares) at Mar. 31, 2026   46,750,000        
Equity at end of period at Mar. 31, 2026 $ 155.8 $ 46.8 28.1 38.6 42.3 0.0
Outstanding shares at beginning of period (in shares) at Dec. 31, 2025 46,650,000 46,650,000        
Equity at beginning of period at Dec. 31, 2025 $ 161.7 $ 46.7 27.4 50.3 37.3 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 29.6          
Outstanding shares at end of period (in shares) at Jun. 30, 2026 47,145,000 47,145,000        
Equity at end of period at Jun. 30, 2026 $ 163.2 $ 47.2 30.3 18.4 66.9 0.4
Outstanding shares at beginning of period (in shares) at Mar. 31, 2026   46,750,000        
Equity at beginning of period at Mar. 31, 2026 155.8 $ 46.8 28.1 38.6 42.3 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares (in shares)   395,000        
Issuance of common shares 2.6 $ 0.4 2.2      
Non-controlling interests on subsidiary acquired 0.4          
Share based compensation 0.0          
Cash distributions to shareholders (20.2)     (20.2)    
Net income (loss) $ 24.6          
Outstanding shares at end of period (in shares) at Jun. 30, 2026 47,145,000 47,145,000        
Equity at end of period at Jun. 30, 2026 $ 163.2 $ 47.2 $ 30.3 $ 18.4 $ 66.9 $ 0.4